Learn more about MACE uses, effectiveness, possible side effects, interactions, dosage, user ratings and products that contain MACE.

Mace is taken by mouth for diarrhea, nausea, vomiting, stomach spasms and pain, and intestinal gas. It is also taken by mouth for treating cancer, kidney disease, increasing menstrual flow; causing a miscarriage, and as a hallucinogen. Mace is applied to the skin to kill pain, especially pain caused by achy joints (rheumatism).

Various medications used for glaucoma, Alzheimer disease, and other conditions (Cholinergic drugs) interacts with NUTMEG AND MACE. Nutmeg can increase a chemical in the body called...

Nov 11, 2024 · Nutmeg is a widely used food spice that has received attention as an alternative hallucinogen. Nutmeg and mace have been used in Indian cooking and folk medicine. In folk medicine, nutmeg has been used to treat gastric disorders and rheumatism, and also as a hypnotic and an aphrodisiac.

Major adverse cardiovascular events (MACE, or major adverse cardiac events) is a composite endpoint frequently used in cardiovascular research. [1] [2] Despite widespread use of the term in clinical trials, the definitions of MACE can differ, which makes comparison of …

Nov 22, 2024 · Mace shows potential as a mild nootropic supplement due to its psychoactive compounds that modulate dopamine and serotonin pathways. These effects may enhance mood, focus, and mental clarity while providing some degree of neuroprotection.

19 hours ago · In fact, biologics with non-TNF targets showed significantly greater MACE rates than did JAK inhibitors (incidence rate ratio [IRR] 1.35, 95% CI 1.10-1.66, after adjusting for baseline factors ...

For patients with diabetes mellitus and TIA/stroke, major societies recommend glucose-lowering agents with benefits in major adverse cardiovascular events (MACE). Not all MACE are equivalent. Improvements in A1c with glucagon 1-receptor …

Conclusions: Concomitant use of antidepressants and NSAIDs moderately elevated the risk of MACE, of which the observed risk appears to be driven by the concomitant use of tricyclic antidepressants and non-selective NSAIDs.

THURSDAY, Aug. 8, 2024 -- For patients with HIV in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) trial, use of abacavir was associated with an increased incidence of major adverse cardiovascular events (MACE), according to a study presented at AIDS 2024, the 25th International AIDS Conference, held from July 22 to 26 in Munich.